Natural killer cells act as an extrinsic barrier for in vivo reprogramming

dc.contributor.authorMelendez, Elena
dc.contributor.authorChondronasiou, Dafni
dc.contributor.authorMosteiro, Lluc
dc.contributor.authorMartínez de Villarreal, Jaime
dc.contributor.authorFernández Alfara, Marcos
dc.contributor.authorLynch, Cian J.
dc.contributor.authorGrimm, Dirk
dc.contributor.authorReal, Francisco X.
dc.contributor.authorAlcamí, José
dc.contributor.authorCliment Vidal, Núria
dc.contributor.authorPietrocola, Federico
dc.contributor.authorSerrano Marugán, Manuel
dc.date.accessioned2022-05-09T07:53:46Z
dc.date.available2022-05-09T07:53:46Z
dc.date.issued2022-04-14
dc.date.updated2022-05-06T10:17:27Z
dc.description.abstractThe ectopic expression of transcription factors Oct4, Sox2, Klf4 and Myc (OSKM) enables reprogramming of differentiated cells into pluripotent embryonic stem cells. Methods based on partial and reversible in vivo reprogramming are a promising strategy for tissue regeneration and rejuvenation. However, little is known about the barriers that impair reprogramming in an in vivo context. We report that natural killer (NK) cells significantly limit reprogramming, both in vitro and in vivo. Cells and tissues at the intermediate states of reprogramming upregulate the expression of NK activating ligands, such as MULT1 and ICAM1. NK cells recognize and kill partially reprogrammed cells in a degranulation-dependent manner. Importantly, in vivo partial reprogramming is strongly reduced by adoptive transfer of NK cells, whereas it is significantly improved by depletion of NK cells. Notably, in the absence of NK cells, the pancreatic organoids derived from OSKM-expressing mice are remarkably large, suggesting the generation of cells with progenitor properties. We conclude that NK cells pose an important barrier for in vivo reprogramming, and this concept may apply to other contexts of transient cellular plasticity.
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina6548062
dc.identifier.issn1477-9129
dc.identifier.pmid35420133
dc.identifier.urihttps://hdl.handle.net/2445/185453
dc.language.isoeng
dc.publisherCompany of Biologists Ltd
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1242/dev.200361
dc.relation.ispartofDevelopment, 2022, vol.149, num. 8, p. dev200361
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/669622/EU//CELLPLASTICITY
dc.relation.urihttps://doi.org/10.1242/dev.200361
dc.rightscc by (c) Melendez, Elena et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
dc.subject.classificationCèl·lules mare embrionàries
dc.subject.classificationCèl·lules K
dc.subject.classificationSistema immunitari
dc.subject.otherEmbryonic stem cells
dc.subject.otherKiller cells
dc.subject.otherImmune system
dc.titleNatural killer cells act as an extrinsic barrier for in vivo reprogramming
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Melendez E et al_Dev_2022.pdf
Mida:
8.21 MB
Format:
Adobe Portable Document Format